Binge Eating Disorder

Current Binge Eating Disorder News & Information

0

Is Holiday Binge Eating Really Bad? Americans Gain 1 Pound Between ... - Yibada (English Edition)

Is Holiday Binge Eating Really Bad? Americans Gain 1 Pound Between …Yibada (English Edition)“Though a one-pound weight gain over the holiday season may not seem like much, the truth is most Americans do not lose that pound,” said Cleveland Clinic’s Heart and Vascular Institute’s registered dietician Kate Patton. Patton …read more

0

Holiday Binge Eating Not Bad? Americans Gain 1 Pound Between Thanksgiving ... - Yibada (English Edition)

Holiday Binge Eating Not Bad? Americans Gain 1 Pound Between Thanksgiving …Yibada (English Edition)“Though a one-pound weight gain over the holiday season may not seem like much, the truth is most Americans do not lose that pound,” said Cleveland Clinic’s Heart and Vascular Institute’s registered dietician Kate Patton. Patton …read more

0

Holiday Binge Eating Is Okay: Experts; Americans Gain 1 Pound Between ... - Yibada (English Edition)

Yibada (English Edition)“Though a one-pound weight gain over the holiday season may not seem like much, the truth is most Americans do not lose that pound,” said Cleveland Clinic’s Heart and Vascular Institute’s registered dietician Kate Patton. Patton said eating without … and more …read more

0

How Bad Is Holiday Binge Eating? Americans Gain 1 Pound Between ... - Yibada (English Edition)

How Bad Is Holiday Binge Eating? Americans Gain 1 Pound Between …Yibada (English Edition)“Though a one-pound weight gain over the holiday season may not seem like much, the truth is most Americans do not lose that pound,” said Cleveland Clinic’s Heart and Vascular Institute’s registered dietician Kate Patton. Patton …read more

0

Holiday Binge Eating Is Okay: Experts; Americans Gain 1 Pound Between ... - Yibada (English Edition)

Holiday Binge Eating Is Okay: Experts; Americans Gain 1 Pound Between …Yibada (English Edition)“Though a one-pound weight gain over the holiday season may not seem like much, the truth is most Americans do not lose that pound,” said Cleveland Clinic’s Heart and Vascular Institute’s registered dietician Kate Patton. Patton …read more

0

Melissa McCarthy Stocks Up On Chinese Food Amid Health Concerns Of Yo-Yo ... - RadarOnline

Melissa McCarthy Stocks Up On Chinese Food Amid Health Concerns Of Yo-Yo …RadarOnlineMelissa McCarthy stepped out on Christmas Eve to grab Chinese food with her family, as an insider tells The National ENQUIRER the A-list comedy queen has been “binge eating” over the past month, possibly putting her health …read more

0

Komaroff: Eating disorders not confined to teens - Bloomington Pantagraph (blog)

Komaroff: Eating disorders not confined to teensBloomington Pantagraph (blog)The type of disordered eating you’ve described sounds like bulimia nervosa. People with bulimia go through cycles of binge eating followed by purging. While on a binge, a person with bulimia may eat an entire cake rather than one or two …read more

0

LCS Therapeutics collaborates to commercialize patent on method to treat binge ... - News-Medical.net

LCS Therapeutics collaborates to commercialize patent on method to treat binge …News-Medical.netLCS Therapeutics announced today that it has entered into a strategic collaboration with Lucerne Biosciences, LLC (“Lucerne Biosciences”) to commercialize U.S. Patent No. 8,318,813 entitled “Method of Treating Binge Eating Disorder.” Patent ‘813 … and more …read more

0

LCS Therapeutics and Lucerne Biosciences to Commercialize '813 Patent for ... - The Providence Journal

LCS Therapeutics and Lucerne Biosciences to Commercialize ‘813 Patent for …The Providence JournalPatent ‘813 features claims that encompass the use of the amphetamine prodrug lisdexamfetamine dimesylate (l-lysine-d-amphetamine) alone, or in combination with other pharmacologic therapies, for the treatment of Binge Eating Disorder (BED) according … and more …read more

0

LCS Therapeutics and Lucerne Biosciences to Commercialize '813 Patent for ... - Stockhouse

LCS Therapeutics and Lucerne Biosciences to Commercialize ‘813 Patent for …Stockhouse8,318,813 entitled “Method of Treating Binge Eating Disorder.” Patent ‘813 features claims that encompass the use of the amphetamine prodrug lisdexamfetamine dimesylate (l-lysine-d-amphetamine) alone, or in combination with other pharmacologic … and more …read more

1 583 584 585 586 587 594